Overview
Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Indication
No indication information available.
Associated Conditions
- Capillary fragility
- Chronic Venous Insufficiency (CVI)
- Haemorrhoids
- Lymphoedemas
- Superficial Venous Insufficiency, Varicose Veins
- Venous Insufficiency of Leg
- Varicosities of the great saphenous vein
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/04/09 | Phase 1 | Recruiting | Westlake University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| TROXERUTINA KERN PHARMA 100 mg/ml SOLUCION ORAL EFG | 70904 | SOLUCIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| ESBERIVEN 100 mg/ml SOLUCION ORAL | 53004 | SOLUCIÓN ORAL | Medicamento Sujeto A Prescripción Médica | Commercialized | |
| VENORUTON OXERUTINAS 1 G POLVO PARA SOLUCION ORAL | Laboratorio Stada S.L. | 64262 | GRANULADO PARA SOLUCIÓN ORAL | Sin Receta | Commercialized |
| VARILIV TROXERUTINA 1 g GRANULADO PARA SOLUCION ORAL | Laboratorios Cinfa S.A. | 74423 | GRANULADO PARA SOLUCIÓN ORAL | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.